Leerink analyst Michael Cherny downgraded Patterson Companies (PDCO) to Market Perform from Outperform with a price target of $31.35, up from $29, based on the takeout price agreed upon by Patient Square Capital following the company’s go-private transaction. The firm views the multiple paid for the transaction as “reasonable” and thus sees any meaningful “topticking” bid as unlikely, the analyst tells investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PDCO:
- Patterson Companies to be acquired by Patient Square for $31.35 per share
- Patterson Companies price target lowered to $24 from $26 at Piper Sandler
- Patterson Companies price target lowered to $25 from $28 at Baird
- Patterson Companies Reports Mixed Q2 Fiscal 2025 Results
- Patterson Companies price target lowered to $24 from $25 at Stifel